AeroLeads people directory · profile
Frank Femia Email & Phone Number
Director of Underwriting
at
Falcon Ridge Management Ltd.
1 work email found
@dechra.com
2 phones found area 773 and 617
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Director of Underwriting
Location
Portland, Maine, United States
Company size
Who is Frank Femia? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Frank Femia is listed as Director of Underwriting at Falcon Ridge Management Ltd., a with 6 employees, based in Portland, Maine, United States. AeroLeads shows a work email signal at dechra.com, phone signal with area code 773, 617, and a matched LinkedIn profile for Frank Femia.
Frank Femia previously worked as Director, US Product Development at Dechra Pharmaceuticals Plc and Associate Director, CMC Product Development at Us Worldmeds. Frank Femia holds Phd, Inorganic Chemistry from Syracuse University.
Company email context
Email format at Falcon Ridge Management Ltd.
This section adds company-level context without repeating Frank Femia's masked contact details.
{first}.{last}@dechra.com
86% confidence
AeroLeads found 1 current-domain work email signal for Frank Femia. Compare company email patterns before reaching out.
Profile bio
About Frank Femia
Pharmaceutical research and development scientist focused on the design and synthesis of innovative drugs to address unmet clinical needs, in addition to the discovery of novel imaging agents for SPECT, PET, MRI and Fluorescence microscopyBroad and in-depth knowledge and experience in discovery, pre-clinical and clinical development, quality assurance as well as regulatory affairs Strong background and experience in scale-up, optimization, process and analytical development, validation, formulation, manufacturing, purification and analysisSpecialties: Discovery through mid-stage clinical development of pharmaceuticalsStrong background and knowledge in pharmaceutical development, including process design, QC method development, current Good Manufacturing Practice (cGMP), Good Laboratory Practice (GLP), Chemistry, Manufacturing and Controls (CMC) and related guidelines from the U.S. Food and Drug AdministrationScientific writing and review of CMC related documentation for regulatory submissions (INDs) and amendments
Listed skills include Chemistry, Process Design, Clinical Development, Gmp, and 45 others.
Current workplace
Frank Femia's current company
Company context helps verify the profile and gives searchers a useful next step.
Falcon Ridge Management Ltd.
9 roles
Frank Femia work experience
A career timeline built from the work history available for this profile.
Director, Us Product Development
Current
Dec 2017 - Present
Associate Director, Cmc Product Development
Nov 2015 - Dec 2016
Senior Manager, Product Development
Provide chemistry, manufacturing and control (CMC) cross-functional strategic direction and tactical management for Putney’s development programs (including topical, soft gelatin capsule, and sterile lyophilized products)Manage and oversee the development of drug formulations and/or transfer of development activities with Putney contractorsReview and approve protocols/reports related to the manufacturing, analytical and stability of drug substances and drug productsProvide scientific guidance to setting up specifications, analytical method validation/verification/ transfer, OOS/deviation handling, CAPAs, process validation, facility qualification, stability studies, packaging, establishment of drug impurity profile and characterization for APIsContribute and review regulatory documents and communications for R&D programsSupport technical evaluation of portfolio development, new business opportunities and due diligence activities
Jan 2014 - Nov 2015
Manager, Product Development
Jan 2013 - Jan 2014
Cmc Director
Responsible for the oversight and execution of chemistry, manufacturing and control (CMC) related activities for small molecule drug candidates through all stages of clinical development, including preparation of regulatory documents and adherence to ongoing compliance requirements. Extensive interactions with external CMOs/CROs, regulatory agencies and corporate partners.Participate on cross-functional teams in order to support relevant CMC development requirements through all phases of development, meet on-going supply/inventory needs, andmanage required change control.Review and approve reports, specifications, certificates of analysis, batch records and ensure that all supporting documentation is maintained in accordance with cGMP and applicable regulatory authorities.
May 2011 - Jan 2013
Senior Scientist
Molecular Insight Pharmaceuticals
Independently designed and developed innovative process methodologies for the radio-synthesis of small molecule and peptide based radiopharmaceuticals for targeted diagnostic (SPECT & PET) and therapeutic applications in nuclear medicine Development and manufacturing of preclinical/clinical drug products: Ultratrace™ mIBG I-123 (and I-131) for the detection (and treatment) of neuroendocrine tumors; I-123 Prostate Specific Membrane Antigen (PSMA) Inhibitor (Trofex™) for the detection of metastatic prostate cancer; I-131 PSMA Inhibitor for the treatment of metastatic prostate cancer; I-131 benzamide derivative (Solazed™) for the treatment of metastatic melanoma; Tc-99m PSMA Inhibitor (Tc-iPSMA) for the detection of metastatic prostate cancer; as well as edotreotide Y-90 (Onalta™) and edotreotide In-111 for the treatment and detection of neuroendocrine tumors, respectively Analyzed radiopharmaceuticals using HPLC (UV-Vis and Radiometric), radio-TLC (ITLC-SG) and other methodologies to assess appearance; container integrity; radiochemical identity and purity; radionuclidic identity and purity; specific activity; radioactive strength and concentration; pH; bacterial endotoxin content; osmolarity; and sterility Validated analytical test methods for radiopharmaceuticals and established QC release specifications Transferred radiopharmaceutical drug product production technologies and test methods to clinical manufacturing sitesReported and presented findings in the literature (5 published articles) and at scientific meetings (8 presentations)
Jul 2008 - Feb 2011
Scientist Ii
Molecular Insight Pharmaceuticals
Manufactured radiopharmaceuticals to support Phase I and II clinical studiesDesign, synthesis, formulation and characterization of chemical impurities in drug products to support preclinical toxicology studiesSynthesized and characterized bifunctional chelating agents and precursors for attachment to biomoleculesDesign, synthesis, characterization and in vivo evaluation of a series of radiopharmaceutical complexes for cardiac, renal tubular secretion and infection studiesSynthesized and evaluated a series of high affinity Angiotensin Converting Enzyme (ACE) inhibitors for the detection, treatment and management of patients with cardiac disorders such as ventricular hypertrophy, myocardial infarction and congestive heart failureDesign, synthesis and evaluation of piperidine based ligands with high selectivities for each of the monoamine transporters [dopamine (DAT), serotonin (SERT) and norepinephrine (NET)]mg to multi-gram organic synthesis techniques and related methods of purification and analysis, including a variety of chromatography (flash silica, reverse phase, anion exchange and reverse phase HPLC) and spectroscopy (UV-Vis, Mass (ESI), NMR)Analytical testing, characterization and structure elucidation of small molecules, peptides, raw materials, chemical and active pharmaceutical intermediates using HPLC, LC/MS, NMR and GC spectroscopyReported and presented findings in the literature (4 published articles) and at scientific meetings (16 presentations)
May 2004 - Jul 2008
Post-Doctoral Fellow In Chemistry/Biology
Designed and synthesized spectroscopic and magnetic probes incorporating novel functionality for in vivo magnetic resonance (MR) and fluorescence microscopic imaging of biological systems with emphasis on nerve patterning, regulation of cell lineage and gene expressionDeveloped bioactivated MRI agents capable of reporting on the anatomical and physiological function of cellular processesSynthesized and characterized physiologically responsive magnetic resonance (MR) contrast agents activated by enzymes such as β-galactosidase and β-glucuronidasePrepared racemic and diastereomerically pure enzyme-activated MR contrast agents and studied the differences in relaxometric properties and coordination geometry resulting from variations in linker stereochemistry between the macrocycle and sugar moietyMeasured the hydration number, water residence lifetime and longitudinal relaxation rates for enzyme-activated MR contrast agentsUV-Vis, Fluorescence, Mass (ESI & APCI), NMR, FT-IR and T1 relaxation analysisRoutine performance of H-1, C-13, P-31, O-17 and Sn-119 NMR spectroscopy experiments Structure elucidation using NMR spectroscopy (H-1, C-13, two-dimensional), LC/MS, IR and UV-Vis analysis
Apr 2001 - Apr 2004
2 education records
Frank Femia education
Phd, Inorganic Chemistry
Syracuse University
Ba, Chemistry
Hamilton College
FAQ
Frequently asked questions about Frank Femia
Quick answers generated from the profile data available on this page.
What company does Frank Femia work for?
Frank Femia works for Falcon Ridge Management Ltd..
What is Frank Femia's role at Falcon Ridge Management Ltd.?
Frank Femia is listed as Director of Underwriting at Falcon Ridge Management Ltd..
What is Frank Femia's email address?
AeroLeads has found 1 work email signal at @dechra.com for Frank Femia at Falcon Ridge Management Ltd..
What is Frank Femia's phone number?
AeroLeads has found 2 phone signal(s) with area code 773, 617 for Frank Femia at Falcon Ridge Management Ltd..
Where is Frank Femia based?
Frank Femia is based in Portland, Maine, United States while working with Falcon Ridge Management Ltd..
What companies has Frank Femia worked for?
Frank Femia has worked for Falcon Ridge Management Ltd., Dechra Pharmaceuticals Plc, Us Worldmeds, Putney, Inc., and Iba.
How can I contact Frank Femia?
You can use AeroLeads to view verified contact signals for Frank Femia at Falcon Ridge Management Ltd., including work email, phone, and LinkedIn data when available.
What schools did Frank Femia attend?
Frank Femia holds Phd, Inorganic Chemistry from Syracuse University.
What skills is Frank Femia known for?
Frank Femia is listed with skills including Chemistry, Process Design, Clinical Development, Gmp, Glp, Fda, Ind, and Cmc.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial